Abaxis new CRP assay receives FDA marketing clearance Abaxis.

In these regions, CRP is trusted as a typical test in general health screenings, and as part of routine clinical practice. Usage of the test continues to grow as Physicians find out about its availability and simplicity at the point-of-care. Resource Abaxis, Inc.. Abaxis’ new CRP assay receives FDA marketing clearance Abaxis, Inc. , a medical products organization manufacturing point-of-care blood analysis systems, announced that the U today.S., an it solutions provider, offers been awarded a $3.5M contract by GSA’s National Capital Region to support the Department of Health and Human Providers FTS2001-Networx Transition Program Management Office. ‘Our team’s domain knowledge and experience provides us insight into the current environment of how procedures and technologies could be leveraged to raised support the Division of Health insurance and Human Services’ crucial mission later on,’ said Julie S.